SCALP PSORIASIS
Clinical trials for SCALP PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new SCALP PSORIASIS trials appear
Sign up with your email to follow new studies for SCALP PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising psoriasis drug tested specifically in skin of color patients
Disease control CompletedThis study tested the drug guselkumab in 213 adults with skin of color who have moderate-to-severe plaque or scalp psoriasis. Participants received either the drug or a placebo, and researchers measured how much their psoriasis cleared up after 16 weeks. The goal was to see if gu…
Matched conditions: SCALP PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New hope for psoriasis sufferers: risankizumab trial targets genital and scalp symptoms
Disease control CompletedThis study tested the drug risankizumab (Skyrizi) in 214 adults with moderate to severe genital or scalp psoriasis. Participants received either the drug or a placebo for 16 weeks, then all received the drug for up to a year. The goal was to see if the drug could clear or nearly …
Matched conditions: SCALP PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New shampoo shows promise for itchy scalp psoriasis
Symptom relief CompletedThis study tested whether a special shampoo called Daxxin Psoriasis Shampoo can safely reduce symptoms of moderate scalp psoriasis. Forty-one adults used the shampoo 3 to 7 times a week for 6 weeks. Researchers measured changes in scalp redness, thickness, and flaking, as well as…
Matched conditions: SCALP PSORIASIS
Phase: NA • Sponsor: Daxxin AB • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC